Fennec Pharmaceuticals Inc
Price
FilingsNewest: 8-K, Other eventsSep 17 →InsidersNo open-market buys. 7 insiders sold $10.8M, 10 of 16 sales on a 10b5-1 plan.→Financing →PeersClosest companies: XERS, MIRM, AXSM→
From the filings
Figures
- Revenue
- $59.2Mlast 12 months
- Net income
- −$3.3Mlast 12 months
- Operating cash flow
- −$5.8Mlast 12 months
- Cash and equivalents
- $41.2Mat the last balance sheet
- Total debt
- $19.4Mat the last balance sheet
- Shares outstanding
- 35.0M shareson issue